News
A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...
Eli Lilly's Mounjaro (Tirzepatide), a dual GIP and GLP-1 receptor agonist, has launched in India, generating buzz as a weight ...
Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the ...
KATIE Price has revealed her heartbreak after learning that son Harvey’s weight has now crept up to nearly 30 stone. The ...
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide). The ...
The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...
A HEALTHCARE worker has insisted Mounjaro has been "life-changing" after she shed five stone in seven months. Connie Bulloch, from Cambuslang, near Glasgow, started using the weight loss jabs in ...
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
Meghan Trainor said she’s been taking Mounjaro for weight loss alongside her husband, ‘Spy Kids’ actor Daryl Sabara. The ...
Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...
Eli Lilly's weight-loss drug, Mounjaro, has sparked significant interest following its India launch. Amid extensive patient ...
Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results